Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    1672911 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma
Condition: AIDS Related Lymphoma
Interventions: Biological: Filgrastim;   Biological: Rituximab;   Drug: EPOCH

Indicates status has not been verified in more than two years